Delivery Order SPE2DB20D2014-SPE2DB25FB50M

Award Date 4/1/25
Potential Completion Date 4/2/25
Potential Value $7.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,887.80 firm fixed-price delivery order is for the supply of 4567767272 ! NALBUPHINE 200 MG/10 ML VIAL 10ML, with an ultimate completion date of April 2, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,261.05, is a Firm Fixed Price Delivery Order for the supply of NALBUPHINE 200 MG/10 ML VIAL 10ML medical products. The contract has an ultimate completion date of March 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,824.74 firm fixed-price delivery order is for the supply of 10 mL vials of the medication Nalbuphine 200 mg. The contract has a completion date of July 5, 2024 and was awarded on July 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $2,036.86 for the supply of NALBUPHINE 100 MG/10 ML VIAL 10ML. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 18, 2025, with a completion date of February 19, 2025. This contract represents a small portion of Amerisourcebergen's broader contracting relationship with the federal government, as the company...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office division, involves the delivery of NALBUPHINE 200 MG/10 ML VIAL 10ML pharmaceutical products. The award, valued at $4,561.80, was made by the Defense Logistics Agency (DLA) on August 14, 2024, with a completion date of August 15, 2024. This is a Firm Fixed Price Delivery Order contract, and there is no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal...
This federal contract award, valued at $4,047.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,789.24 firm fixed-price contract is for the delivery of 4567675477 ! NALBUPHINE 100 MG/10 ML VIAL 10ML, a specialty medication. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, with a ceiling value of $1,563.28, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the delivery of 4,565,157,975 units of the pharmaceutical product Nalbuphine 100 mg/10 ml vial, 10 ml, with an ultimate completion date of July 17, 2024. This award is not associated with a set-aside. Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, has...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Nalbuphine 100 mg/10 mL vials. The award, with a ceiling value of $2,946.07, is a Firm Fixed Price Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC enables the DLA to efficiently procure a comprehensive range of medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,067.69, is for the delivery of the medication Nalbuphine 10 mg/ml ampul. The contract is a firm fixed-price delivery order with a completion date of March 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB50M
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,514.77 Firm Fixed Price Delivery Order is for the supply of 4567760088 - NALBUPHINE 200 MG/10 ML VIAL 10ML. The contract has an ultimate completion date of April 2, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract does not have a set-aside designation, indicating open competition.

Generated 7/1/25, 8:32 AM